Results 21 to 30 of about 2,796,329 (209)

Validation of the detection method for residual human coagulation factor Ⅺ in human prothrombin complex

open access: yesZhongguo shuxue zazhi, 2023
Objective To establish an enzyme-linked immunosorbent assay (ELISA) method for the determination of residual human coagulation factor Ⅺ in human prothrombin complex and validate the method.
Yong LIU   +8 more
doaj   +1 more source

Trends in Biological Ammonia Production

open access: yesBioTech, 2023
Food production heavily depends on ammonia-containing fertilizers to improve crop yield and profitability. However, ammonia production is challenged by huge energy demand, the release of ~2% of global CO2, and political instability. To mitigate this challenge, many research efforts have developed bioprocessing technologies to make biological ammonia ...
Adewale Adeniyi   +4 more
openaire   +3 more sources

Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study

open access: yesHuman Vaccines & Immunotherapeutics, 2022
To control seasonal influenza epidemics in elders, a quadrivalent, inactivated, split-virion influenza vaccine (IIV4) comprising A and B lineages is produced for young individuals and adults aged ≥60 years.
Renfeng Fan   +15 more
doaj   +1 more source

Repeat-Dose Toxicity of Candidate Omicron COVID-19 Vaccine in Sprague-Dawley Rats

open access: yesCOVID, 2022
Due to a large number of mutations in the spike protein and immune escape, the Omicron variant (B.1.1.529) has become a predominant variant of concern (VOC) strain.
Yuxiu Zhao   +18 more
doaj   +1 more source

Advances in Next-Generation Coronavirus Vaccines in Response to Future Virus Evolution

open access: yesVaccines, 2022
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread to more than 230 countries and territories worldwide since its outbreak in late 2019. In less than three years, infection by SARS-CoV-2 has
Lili Li   +8 more
doaj   +1 more source

Study on thedistribution of high titer neutralizing antibody against human cytomegalovirus in plasma donors

open access: yesZhongguo shuxue zazhi, 2022
Objective To investigate the distribution of plasma donors with high titer neutralizing antibodies against human cytomegalovirus (HCMV) in the general plasma donor population. Methods 920 plasma samples of Taibang were tested in April 2014 to investigate
Junying SHEN   +5 more
doaj   +1 more source

Copper-containing mesoporous bioactive glass promotes angiogenesis in an in vivo zebrafish model [PDF]

open access: yes, 2017
The osteogenic and angiogenic responses of organisms to the ionic products of degradation of bioactive glasses (BGs) are being intensively investigated. The promotion of angiogenesis by copper (Cu) has been known for more than three decades. This element
Aguiar   +71 more
core   +2 more sources

Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments

open access: yesViruses, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused huge social and economic distress. Given its rapid spread and the lack of specific treatment options, SARS-CoV-2 needs to be inactivated according to strict biosafety measures during
Shouzhi Yu   +12 more
doaj   +1 more source

100 years of microbial electricity production : three concepts for the future [PDF]

open access: yes, 2012
Bioelectrochemical systems (BES) have been explored according to three main concepts: to produce energy from organic substrates, to generate products and to provide specific environmental services.
Arends, Jan, Verstraete, Willy
core   +2 more sources

Integrated Multi-Omic Characterization of the Detachment Process of Adherent Vero Cells with Animal-Based and Animal-Origin-Free Enzymes

open access: yesCells, 2022
Cell detachment techniques using animal-derived enzymes are necessary for the production of biopharmaceuticals that are made with the help of adherent cell cultures, although the majority of protein therapeutics (>USD 100 billion of income per year) are ...
Shouzhi Yu   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy